Cancer vaccines

John T. Schiller, Douglas R. Lowy, Ian H. Frazer, Olivera J. Finn, Eduardo Vilar, H. Kim Lyerly, Sacha Gnjatic, Neeha Zaidi, Patrick A. Ott, Vinod P. Balachandran, Pierre Yves Dietrich, Denis Migliorini, Robert H. Vonderheide, Susan M. Domchek

Research output: Contribution to journalComment/debate

4 Scopus citations


Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical development, plus the challenges we need to overcome for their broad implementation.

Original languageEnglish
Pages (from-to)559-564
Number of pages6
JournalCancer Cell
Issue number6
StatePublished - 13 Jun 2022


Dive into the research topics of 'Cancer vaccines'. Together they form a unique fingerprint.

Cite this